Home > Resources > Whitepapers > African Perspectives on Genetically Modified Crops

African Perspectives on Genetically Modified Crops

The use of genetically modified organisms (GMOs) to boost agricultural productivity is often touted in Washington policy circles as a potentially powerful tool for boosting agricultural productivity and reducing food insecurity in Africa. That confidence has not been shared by African governments, many of whom remain wary of transgenic technologies. The Green Revolution in agriculture passed largely unnoticed in Africa. While in Asia and Latin America the introduction of improved crop varieties and the application of scientific farming methods enabled food production to outstrip population growth, in Africa agricultural productivity actually declined. On a per capita basis, Africa’s farms produced almost a fifth less in 2005 than they did in 1970.1 Africa currently imports a quarter of its food, even though 70 percent of its people are engaged in agriculture.

Spotlight

Esco

As a world leader in the development of laboratory, medical and pharmaceutical equipment solutions, Esco distributes in more than 100 countries, with more than 300 independent distributor partners worldwide.

OTHER WHITEPAPERS

Lipid Nanoparticle and Liposome

whitePaper | September 12, 2022

Lipid nanoparticles (LNPs) and liposomes are variations of lipid-based drug carriers differing in their internal structure.

Next Generation Therapies and related Life Sciences topics

whitePaper | January 16, 2022

All gene therapies insert engineered DNA/RNA into living cells to make or modify new proteins

Cell Lysate Sample Handling with Simoa Bead-Based Assays

whitePaper | November 12, 2019

This document describes a novel Quanterix lysate diluent for running lysate samples with Simoa assays diluent.

Pioneering Cell and Gene Therapy Solutions From Discovery to the Clinic

whitePaper | April 14, 2020

Your vision is to create revolutionary cell and gene therapies to treat life threatening diseases. Bio-Techne and its family of brands is on this journey with you. As a full-solution ancillary reagent and services provider, we will stand by you, providing flexible and pioneering tools to simplify your workflow. From CAR T cells to pluripotent stem cells, let us help you get your therapy to the patients that need it

Understanding Single-Pass Tangential Flow Filtration and the New Era of Bioprocessing

whitePaper | December 22, 2022

Single-pass tangential flow filtration (SPTFF) technology from Pall Corporation is revolutionizing current and future bioprocessing platforms with its implementations in biotech, vaccine and plasma industries. Its features are protected by a portfolio of patents[1-6].

Osmolality monitoring for UF/DF and CEXcapture of mAbs from mammalian cell cultures

whitePaper | July 25, 2022

The goal of each process step is to facilitate the production of a consistent product with high yield, quality, purity, and functionality. Throughout each step various Process Analytical Tools (PAT) are used to ensure quality and production metrics are maintained.

Lipid Nanoparticle and Liposome

whitePaper | September 12, 2022

Lipid nanoparticles (LNPs) and liposomes are variations of lipid-based drug carriers differing in their internal structure.

Next Generation Therapies and related Life Sciences topics

whitePaper | January 16, 2022

All gene therapies insert engineered DNA/RNA into living cells to make or modify new proteins

Cell Lysate Sample Handling with Simoa Bead-Based Assays

whitePaper | November 12, 2019

This document describes a novel Quanterix lysate diluent for running lysate samples with Simoa assays diluent.

Pioneering Cell and Gene Therapy Solutions From Discovery to the Clinic

whitePaper | April 14, 2020

Understanding Single-Pass Tangential Flow Filtration and the New Era of Bioprocessing

whitePaper | December 22, 2022

Single-pass tangential flow filtration (SPTFF) technology from Pall Corporation is revolutionizing current and future
bioprocessing platforms with its implementations in biotech, vaccine and plasma industries. Its features are
protected by a portfolio of patents[1-6].

Osmolality monitoring for UF/DF and CEXcapture of mAbs from mammalian cell cultures

whitePaper | July 25, 2022

The goal of each process step is to facilitate the production of a consistent product with high yield, quality, purity, and
functionality. Throughout each step various Process Analytical Tools (PAT) are used to ensure quality and production metrics
are maintained.

More Whitepapers

Spotlight

Esco

Events

8th International Conference on Bio-Sensing Technology

Conference

8th International Conference on Bio-Sensing Technology

Conference